Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8962886 | Chest | 2018 | 27 Pages |
Abstract
Our conclusions parallel those of previous investigations of the fragility of RCT outcomes; we found that some outcomes used to support recommendations in AT10 are fragile. We recommend that the fragility index and fragility quotient be adopted as measures of robustness of clinical trial outcomes.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Elizabeth BS, Cole BS, Jonathan DO, Justin DO, Matt PhD,